Família ABC Arquivos Brasileiros de Cardiologia International Journal of Cardiovascular Sciences ABC Heart Failure & Cardiomyopathy ABC Imagem Cardiovascular
Português English
Família ABC
Português English
  • Sobre
    • Sobre a Família ABC
    • Regimento Interno
    • Conselho Editorial
    • Sociedade Brasileira de Cardiologia (SBC)
  • Edições
  • Diretrizes da SBC
  • Conteúdos
    • Vídeos
    • Podcasts
    • Notícias
  • Sobre
    • Sobre a Família ABC
    • Regimento Interno
    • Conselho Editorial
    • Sociedade Brasileira de Cardiologia (SBC)
  • Edições
  • Diretrizes da SBC
  • Conteúdos
    • Vídeos
    • Podcasts
    • Notícias

Família ABC

  • Família ABC
  • Arquivos Brasileiros de Cardiologia
  • International Journal of Cardiovascular Sciences
  • ABC Heart Failure & Cardiomyopathy
  • ABC Imagem Cardiovascular
Buscar em

Nenhum conteúdo encontrado.

Revistas
Ordenação
Tipos de artigo
Outros

  1. Início
  2. Palavra-chave: Dyslipidemia
IJCS
Original Article

HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease

Matheus Alves Pacheco et al. Silvia Meyer Cardoso Michele Honicky Yara Maria Franco Moreno … Luiz Rodrigo Augustemak de Lima Camila Souza Marcos Isabela de Carlos Back

Abstract

Background

Children and adolescents with congenital heart disease may be more likely to develop atherogenic cardiovascular diseases in adulthood. Therefore, the early identification of risk factors and intervention in childhood may be crucial for a good quality of life and longevity.

Objectives

To describe the distribution of high-density lipoprotein-cholesterol (HDL-c) levels and its association with socioeconomic, clinical and cardiovascular risk factors in children and adolescents with congenital heart disease.

Methods

Cross-sectional study with children and adolescents aged between 5 and 18 years, with congenital heart disease. Socioeconomic, clinical and cardiovascular risk factors were evaluated. HDL-c concentrations were evaluated by the direct method and categorized as desirable (>45 mg/dL), borderline (40-45 mg/dL) and low (<40 mg/dL). We also assessed the “undesirable” levels, consisting of the sum of “borderline” and “low” values for comparative purposes. The multivariate logistic regression analysis was used to evaluate the factor associated with undesirable HDL-c levels. A p<0.05 value was adopted as statistically significant.

Results

Mean HDL-c was 51.2 mg/dL (SD 12.6), with a prevalence of 33.2% of undesirable HDL-c. In the multivariate analysis, C-reactive protein levels ≥ 3mg/dL (OR 3.26; 95% CI 1.32-8.04), age ≥ 10 years old (OR: 2.11; 95% CI 1.12-3.99) and undesirable levels of triglycerides (OR 2.21; 95% CI 1.13-4.75) were associated with undesirable HDL-c.

Conclusion

In this sample of children and adolescents with congenital heart disease, almost one third presented low or borderline HDL-c levels. Age ≥10 years, C-reactive protein and triglycerides were associated with undesirable HDL-c levels. These factors should be considered in the prevention of cerebrovascular diseases in adulthood in this population.

  • Adolescent
  • Atherosclerosis
  • Child
  • cholesterol
  • Congenital/genetics
  • Dyslipidemia
  • HDL-Cholesterol/genetics
  • Heart Defects
  • Risk Factors
Ler artigo completo
Creative Commons Attribution (CC BY) Creative Commons license
19/08/2022 DOI: 10.36660/ijcs.20210106
IJCS
Original Article

Treatment Eligibility and Therapeutic Responses of an Ecuadorian Population at High Cardiovascular Risk Based on the ATP III Guidelines

Isabel Hernández et al. Andrea Estrella Jorge Salazar Yan Duarte … Edmundo Torres Camilo López Santiago Terán Alejandra Mendoza Enrique Terán

Abstract

Background

The Adult Treatment Panel III (ATPIII) guidelines aim to reduce cardiovascular morbidity and mortality. In Ecuador, 20% of people have high LDL cholesterol levels, and 39% have high triglyceride levels.

Objective

To analyze lipid-lowering regimens in Ecuadorian patients and determine the achievement rate of the ATPIII goals for lipid profile.

Methods

Using a retrospective analysis, 385 subjects older than 30 years, who received pharmacological treatment for dyslipidemia for at least three months was randomly selected from institutions at two large cities in Ecuador. Data were collected from patients’ medical records and analyzed by chi-square test or paired t-test; p-values less than 0.05 were considered significant.

Results

Baseline total cholesterol values were above 200 mg/dL in 75% of subjects, LDL-c values above 129 mg/dL in 83% of subjects and triglycerides values above 150 mg/dL in 79% of subjects. Most (n = 253, 95.8%) patients at very high cardiovascular risk were taking statins, 50% of them atorvastatin. Considering the ATPIII guidelines’ goals, only 24 subjects (19%) at high CV risk achieved an LDL-c < 100 mg/dl, while a significantly lower percentage (p = 0.04) of patients at very high risk reached an LDL-c < 70mg/dl (11%; n = 30).

Conclusion

These data indicate a low rate of compliance with the ATPIII guidelines, independent of the medication used or duration of the treatment. This may be attributed to the prescription of low doses of medication and a therapy targeting isolated lipid fractions rather than a complete lipid profile. (Int J Cardiovasc Sci. 2020; 33(4):371-376)

  • Cardiovascular Diseases/prevention and control
  • cholesterol
  • Dyslipidemia
  • Lifestyle
  • Patient Compliance
  • Sedentarism
  • Tabaquism
  • Triglicerides
Ler artigo completo
Creative Commons Attribution (CC BY) Creative Commons license
07/08/2020 DOI: 10.36660/ijcs.20190010 Visualizações 1

Como citar este artigo

EndNote RIS

Formato de Documento Eletrônico (Vancouver)

Pacheco MA, Cardoso SM, Honicky M, Moreno YMF, Lima LRA, Marcos CS, Back IC, et al. HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease. International Journal of Cardiovascular Sciences 2022;35(6):784-93.

Formato de Documento Eletrônico (ABNT)

Pacheco, Matheus Alves; Cardoso, Silvia Meyer; Honicky, Michele; Moreno, Yara Maria Franco; Lima, Luiz Rodrigo Augustemak de; Marcos, Camila Souza; Back, Isabela de Carlos. HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease. International Journal of Cardiovascular Sciences, v. 35, n. 6, p. 784-793, ago. 2022.

Formato de Documento Eletrônico (APA)

Pacheco, M. A., Cardoso, S. M., Honicky, M., Moreno, Y. M. F., Lima, L. R. A. , Marcos, C. S., & Back, I. C. (2022). HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease. International Journal of Cardiovascular Sciences, 35(6), 784-793.

Formato de Documento Eletrônico (ISO)

Pacheco, Matheus Alves and Cardoso, Silvia Meyer and Honicky, Michele and Moreno, Yara Maria Franco and Lima, Luiz Rodrigo Augustemak de and Marcos, Camila Souza and Back, Isabela de Carlos. HDL-Cholesterol in Children and Adolescents with Congenital Heart Disease. International Journal of Cardiovascular Sciences [online]. 2022, vol. 35, n. 6, [citado 2026-10-14], pp. 784-793. Disponível em: <https://journals.cardiol.br/article/hdl-cholesterol-in-children-and-adolescents-with-congenital-heart-disease-2/>. ISSN 2359-4802

EndNote RIS

Formato de Documento Eletrônico (Vancouver)

Hernández I, Estrella A, Salazar J, Duarte Y, Torres E, López C, Terán S, et al. Treatment Eligibility and Therapeutic Responses of an Ecuadorian Population at High Cardiovascular Risk Based on the ATP III Guidelines. International Journal of Cardiovascular Sciences 2020;33(4):371-6.

Formato de Documento Eletrônico (ABNT)

Hernández, Isabel; Estrella, Andrea; Salazar, Jorge; Duarte, Yan; Torres, Edmundo; López, Camilo; Terán, Santiago; Mendoza, Alejandra; Terán, Enrique. Treatment Eligibility and Therapeutic Responses of an Ecuadorian Population at High Cardiovascular Risk Based on the ATP III Guidelines. International Journal of Cardiovascular Sciences, v. 33, n. 4, p. 371-376, ago. 2020.

Formato de Documento Eletrônico (APA)

Hernández, I., Estrella, A., Salazar, J., Duarte, Y., Torres, E., López, C., Terán, S., Mendoza, A., & Terán, E. (2020). Treatment Eligibility and Therapeutic Responses of an Ecuadorian Population at High Cardiovascular Risk Based on the ATP III Guidelines. International Journal of Cardiovascular Sciences, 33(4), 371-376.

Formato de Documento Eletrônico (ISO)

Hernández, Isabel and Estrella, Andrea and Salazar, Jorge and Duarte, Yan and Torres, Edmundo and López, Camilo and Terán, Santiago and Mendoza, Alejandra and Terán, Enrique. Treatment Eligibility and Therapeutic Responses of an Ecuadorian Population at High Cardiovascular Risk Based on the ATP III Guidelines. International Journal of Cardiovascular Sciences [online]. 2020, vol. 33, n. 4, [citado 2026-10-14], pp. 371-376. Disponível em: <https://journals.cardiol.br/article/treatment-eligibility-and-therapeutic-responses-of-an-ecuadorian-population-at-high-cardiovascular-risk-based-on-the-atp-iii-guidelines-2/>. ISSN 2359-4802

  • Sobre a Família ABC
  • Regimento Interno
  • Conselho Editorial
  • Sociedade Brasileira de Cardiologia (SBC)

Edições

Diretrizes da SBC

  • Vídeos
  • Podcasts
  • Notícias